9926:HKG
Akeso Inc
HK$97.50
arrow_upward
+1.67%(+1.60) 1D
Sep 23, 4:08:13 PM GMT+8 · HKD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 9926...
Open
HK$96.85
High
HK$100.30
Low
HK$96.15
Mkt. cap
89.81B
Avg. vol.
13.21M
Volume
7.73M
52-wk high
HK$156.00
52-wk low
HK$80.20
EPS
-HK$1.24
No. of employees
4K
Open
HK$96.85
High
HK$100.30
Low
HK$96.15
Mkt. cap
89.81B
Avg. vol.
13.21M
Volume
7.73M
52-wk high
HK$156.00
52-wk low
HK$80.20
EPS
-HK$1.24
No. of employees
4K
News stories
From web sources and news partners
Seeking Alpha
·
2 days ago
Chinese biopharma stocks rally as U.S. signals openness to drug licensing
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees4.08K
FoundedMar 19, 2012
Headquarters-
SectorBiotechnology
Websiteakesobio.com